Evaluation of progression from first to second stage sacral neuromodulation and unplanned device removal.

Most patients (92.2%) progressed to stage 2. Patients with only OAB symptoms had a higher progression rate to stage 2. Single full-stage procedures may be considered in select patients to reduce morbidity, time, and costs.